MedPath

Selection of sedative drug in liver cirrhosis

Not Applicable
Recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0002964
Lead Sponsor
Soon Chun Hyang University Hospital Bucheon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1) Patients diagnosed as liver cirrhosis from age 19-70, and child-pugh class A or B
2) Patients who are going to perform gastroscopy

Exclusion Criteria

1) decompensated liver cirrhosis (Child-pugh class C)
2) history of overt hepatic encephalopathy
3) Evidence of gastrointestinal bleeding
4) Patients who are at risk for sedation with American Society of Anesthesiologists Classification (ASA Class) IV or higher
5) Patients who are anticipated to have a reduced sedative effect due to a history of taking anticonvulsant drugs within 4 weeks

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of minimal hepatic encephalopathy through a Stroop test
Secondary Outcome Measures
NameTimeMethod
Vital sign;Subjective satisfaction of medical staff / patient
© Copyright 2025. All Rights Reserved by MedPath